4//SEC Filing
Riley Jennifer 4
Accession 0001578563-25-000002
CIK 0001534120other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:06 PM ET
Size
5.7 KB
Accession
0001578563-25-000002
Insider Transaction Report
Form 4
Riley Jennifer
Chief Strategy Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-01+150,000→ 150,000 totalExercise: $7.43Exp: 2035-01-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the Option Shares vest on January 1, 2026 and the remainder of the Option Shares will vest in equal monthly installments over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0002047607
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:06 PM ET
- Size
- 5.7 KB